These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29552045)

  • 1. Single Layer Extended Release Two-in-One Guaifenesin Matrix Tablet: Formulation Method, Optimization, Release Kinetics Evaluation and Its Comparison with Mucinex
    Morovati A; Ghaffari A; Erfani Jabarian L; Mehramizi A
    Iran J Pharm Res; 2017; 16(4):1349-1369. PubMed ID: 29552045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desktop 3D printing of controlled release pharmaceutical bilayer tablets.
    Khaled SA; Burley JC; Alexander MR; Roberts CJ
    Int J Pharm; 2014 Jan; 461(1-2):105-11. PubMed ID: 24280018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Press-Coated Aceclofenac Tablets for Pulsatile Drug Delivery: Formulation and In Vitro Evaluations.
    Rashid R; Zaman M; Ahmad M; Khan MA; Butt MH; Salawi A; Almoshari Y; Alshamrani M; Sarfraz RM
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
    Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
    Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation Development and Optimization of Matrix Tablet of Tramadol Hydrochloride.
    Deb P; Singha J; Chanda I; Chakraborty P
    Recent Pat Drug Deliv Formul; 2017; 11(1):19-27. PubMed ID: 27712568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling.
    Li J; Chai H; Li Y; Chai X; Zhao Y; Zhao Y; Tao T; Xiang X
    PLoS One; 2016; 11(8):e0160260. PubMed ID: 27479702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Integrative QbD Approach for the Development and Optimization of Controlled Release Compressed Coated Formulation of Water-Soluble Drugs.
    Shah V; Khambhla E; Nivsarkar M; Trivedi R; Patel RK
    AAPS PharmSciTech; 2022 Apr; 23(5):120. PubMed ID: 35460024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Development, Optimization and Evaluation of Ranolazine Extended Release Tablets.
    Gunda RK; Manchineni PR; Duraiswamy D; Gsn KR
    Turk J Pharm Sci; 2022 Apr; 19(2):125-131. PubMed ID: 35509223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical Design and Optimization of Sustained Release Formulations of Pravastatin.
    Gunda RK; Manchineni PR
    Turk J Pharm Sci; 2020 Apr; 17(2):221-227. PubMed ID: 32454783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Bioadhesive Buccal Tablets of Nicorandil Using a Factorial Approach.
    Kotadiya R; Shah K
    Turk J Pharm Sci; 2020 Aug; 17(4):388-397. PubMed ID: 32939134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
    Khanvilkar KH; Huang Y; Moore AD
    Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride.
    Gambhire MN; Ambade KW; Kurmi SD; Kadam VJ; Jadhav KR
    AAPS PharmSciTech; 2007 Sep; 8(3):E73. PubMed ID: 17915823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of Carboxymethyl-Xyloglucan-Based Tramadol Matrix Tablets Using Simplex Centroid Mixture Design.
    Madgulkar AR; Bhalekar MR; Padalkar RR; Shaikh MY
    J Pharm (Cairo); 2013; 2013():396468. PubMed ID: 26555977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design.
    Soroush H; Ghorbani-Bidkorbeh F; Mortazavi SA; Mehramizi A
    Iran J Pharm Res; 2018; 17(4):1150-1163. PubMed ID: 30568675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality by design-based development and in vitro evaluation of dual release tablet of etoricoxib and thiocolchicoside: A novel chronotherapeutic approach for arthritis pain management.
    Sharma A; Singh S; Saini G; Sharma S; Singh B; Choudhary D
    Ann Pharm Fr; 2024 Jul; ():. PubMed ID: 39002854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on Flowability, Compressibility and In-vitro Release of Terminalia Chebula Fruit Powder Tablets.
    Satya Prakash S; Patra ChN; Santanu C; Hemant Kumar P; Patro VJ; Devi MV
    Iran J Pharm Res; 2011; 10(3):393-401. PubMed ID: 24250371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride.
    Momin MM; Kane S; Abhang P
    Front Pharmacol; 2015; 6():144. PubMed ID: 26217229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic Studies in Healthy Subjects for the Development of an Extended-Release Tablet Formulation of Guaifenesin: A 505(b)(2) New Drug Application Approval.
    Vilson L; Owen JS
    Clin Pharmacol Drug Dev; 2013 Jan; 2(1):25-32. PubMed ID: 27121557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on Flowability, Compressibility and In-vitro Release ofTerminalia chebula Fruit Powder Tablets.
    Satya Prakash S; Patra N; Santanu C; Hemant Kumar P; Patro J; Devi V
    Iran J Pharm Res; 2011; 10(1):3-11. PubMed ID: 24363675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.